Nurse-Driven Protocol Increased Vaccination for Flu, Pneumonia
A pilot protocol developed at Memorial Sloan Kettering Cancer Center resulted in exponential increases in both influenza and pneumococcal vaccinations in the outpatient setting. (Source: CancerNetwork)
Source: CancerNetwork - July 12, 2018 Category: Cancer & Oncology Authors: Elizabeth Rodriguez, DNP, RN, OCN Source Type: news

Drop in Childhood Pneumococcal, Hib Deaths From 2000 to 2015
THURSDAY, July 12, 2018 -- Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) deaths in children decreased between 2000 and 2015, following introduction of the pneumococcal conjugate vaccine (PCV) and Hib vaccine, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 12, 2018 Category: Pharmaceuticals Source Type: news

What is the Interval For Non-simultaneous Administration of Live Virus Vaccines?
Discussion Vaccines are a mainstay of infectious disease prevention and health promotion. Infants, children and adults benefit from vaccines the most when they are given on the recommended schedules. However there are times when this is not possible as children come to the physician a little early, or a little late, or had unavailable records and so received addition vaccine, etc. There are many questions that arise because of these timing issues such as the one above. Standard vaccine schedules can be reviewed here. Commonly administered vaccines includes: Live-attenuated vaccines Cholera Measles, mumps, rubella (MMR ...
Source: PediatricEducation.org - July 9, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

The Hidden Threat of Meningococcal Disease
Meningococcal bacteria can cause severe illness, even death. The most severe illnesses are meningitis (infection of the lining covering the brain and spinal cord) and sepsis (bloodstream infection). Two types of meningococcal vaccines are available to prevent this infection that can kill up to 15 percent of patients who become infected. (Source: TMA News Room)
Source: TMA News Room - July 3, 2018 Category: Consumer Health News Source Type: news

Adults with suspected meningitis are waiting too long for lumbar puncture
Patients with viral meningitis experience diagnostic delays and inappropriate treatment, study finds Related items fromOnMedica Call to boost students ’ uptake of meningitis vaccination Mass vaccination plan to combat meningitis GPs urged to step up meningitis vaccination programme Vaccine programme halves MenB cases (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 2, 2018 Category: UK Health Source Type: news

Funding two pneumococcal vaccines cost  effective in Canada
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 1, 2018 Category: Drugs & Pharmacology Source Type: news

13-Valent pneumococcal conjugate vaccine better value for money
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 1, 2018 Category: Drugs & Pharmacology Source Type: news

U.S. government statistics reveal that the flu vaccine is the most dangerous vaccine in America
(Natural News) Even the bestselling flu vaccine is only the fifth most popular vaccine in the United States. Prevnar, the vaccine used to prevent infection caused by pneumococcal bacteria; Gardasil, which supposedly prevents cervical cancer; PENTAct-HIB, given to tiny infants to stave off diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b; and... (Source: NaturalNews.com)
Source: NaturalNews.com - June 22, 2018 Category: Consumer Health News Source Type: news

UK public shows strong preference for vaccines that prevent severe illness, particularly for children
The UK public has a clear preference for funding vaccination programmes which protect young children against severe diseases, finds a new study that considered the public ’ s preferences on vaccines available on the NHS. The study suggests that the public ’ s preferences about which vaccines are made available on the NHS, particularly children, are not reflected by the current approach. The Meningitis Research Foundation (MRF)-funded study, led by University of Bristol researchers, is published today [13 June] in PLOS ONE. (Source: University of Bristol news)
Source: University of Bristol news - June 13, 2018 Category: Universities & Medical Training Tags: Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

Huge drop in children dying of meningitis and pneumonia
Hib and pneumococcus once killed thousands a year in the US and Europe, and still do in developing countries. A new Johns Hopkins report finds vaccines are driving down the rate of deaths. (Source: the Mail online | Health)
Source: the Mail online | Health - June 11, 2018 Category: Consumer Health News Source Type: news

Pneumococcal Vaccination (Pneumonia Vaccine)
Title: Pneumococcal Vaccination (Pneumonia Vaccine)Category: Procedures and TestsCreated: 4/12/1999 12:00:00 AMLast Editorial Review: 6/11/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - June 11, 2018 Category: Respiratory Medicine Source Type: news

1.35 million children's lives saved by HiB and pneumococcal vaccines since 2000
(Johns Hopkins University Bloomberg School of Public Health) Childhood deaths from two leading bacterial causes of pneumonia and meningitis, pneumococcus and Hib, declined sharply during the period 2000 to 2015, especially as vaccines against these pathogens were introduced in high-burden countries, according to new estimates from a team led by scientists at Johns Hopkins Bloomberg School of Public Health. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 11, 2018 Category: Infectious Diseases Source Type: news

1.45 million children's lives saved by HiB and pneumococcal vaccines since 2000
(Johns Hopkins University Bloomberg School of Public Health) Childhood deaths from two leading bacterial causes of pneumonia and meningitis, pneumococcus and Hib, declined sharply during the period 2000 to 2015, especially as vaccines against these pathogens were introduced in high-burden countries, according to new estimates from a team led by scientists at Johns Hopkins Bloomberg School of Public Health. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 11, 2018 Category: Infectious Diseases Source Type: news

In quest to leapfrog Pfizer, Peninsula vaccine company gets $85 million injection
The vaccine that halts pneumonia, meningitis and other bloodstream infections is good, but SutroVax Inc. has 85 million new reasons to believe it can do better. The Foster City company added $85 million in a Series C round and welcomed a well-respected biopharmaceutical executive as chairman as it hopes to surpass Pfizer Inc. to produce a broader, next-generation vaccine against a bacterium that causes pneumococcal disease. Thanks to the Series C found l ed by new investor TPG Growth, the five-year-old… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 7, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

In quest to leapfrog Pfizer, Peninsula vaccine company gets $85 million injection
The vaccine that halts pneumonia, meningitis and other bloodstream infections is good, but SutroVax Inc. has 85 million new reasons to believe it can do better. The Foster City company added $85 million in a Series C round and welcomed a well-respected biopharmaceutical executive as chairman as it hopes to surpass Pfizer Inc. to produce a broader, next-generation vaccine against a bacterium that causes pneumococcal disease. Thanks to the Series C found l ed by new investor TPG Growth, the five-year-old… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 7, 2018 Category: American Health Authors: Ron Leuty Source Type: news

In quest to leapfrog Pfizer, Peninsula vaccine company gets $85 million injection
The vaccine that halts pneumonia, meningitis and other bloodstream infections is good, but SutroVax Inc. has 85 million new reasons to believe it can do better. The Foster City company added $85 million in a Series C round and welcomed a well-respected biopharmaceutical executive as chairman as it hopes to jump Pfizer Inc. (NYSE: PFE) to produce a broader, next-generation vaccine against a bacterium that causes pneumococcal disease. Thanks to the Series C found led by new investor TPG Growth, the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 7, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

In quest to leapfrog Pfizer, Peninsula vaccine company gets $85 million injection
The vaccine that halts pneumonia, meningitis and other bloodstream infections is good, but SutroVax Inc. has 85 million new reasons to believe it can do better. The Foster City company added $85 million in a Series C round and welcomed a well-respected biopharmaceutical executive as chairman as it hopes to jump Pfizer Inc. (NYSE: PFE) to produce a broader, next-generation vaccine against a bacterium that causes pneumococcal disease. Thanks to the Series C found led by new investor TPG Growth, the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 7, 2018 Category: American Health Authors: Ron Leuty Source Type: news

SutroVax Announces $85M Series C Financing led by TPG Growth
Provides growth capital to advance pneumococcal vaccine to clinic and beyond Preeminent executive vaccinologist, Moncef Slaoui, appointed Board Chairman Strategic alignment established with Lonza Pharma & Biotech to create end-to-end supply chain ... Biopharmaceuticals, Venture Capital, Personnel SutroVax, pneumococcal vaccine, vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 7, 2018 Category: Pharmaceuticals Source Type: news

Pneumococcal Disease: A Vaccine Preventable Threat
Pneumococcal disease is one of the leading causes of illness among children and seniors. The potentially deadly pneumococcal bacteria causes pneumonia, but it also causes meningitis, sinusitis, sepsis, and ear infections. However, a pneumococcal vaccine can protect both children and adults. (Source: TMA News Room)
Source: TMA News Room - June 5, 2018 Category: Consumer Health News Source Type: news

Research on immune response to PCV in preterm infants earns ESPID-PIDJ Award
(Wolters Kluwer Health) A study showing that pneumococcal vaccination produces a lasting antibody response in preterm infants has been named winner of the inaugural ESPID-PIDJ Award, recognizing the best paper submitted to The Pediatric Infectious Disease Journal (PIDJ) by a member of The European Society for Paediatric Infectious Diseases (ESPID). The Pediatric Infectious Disease Journal, the official journal of the ESPID, is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 29, 2018 Category: International Medicine & Public Health Source Type: news

WHO launches business case for immunization in Africa at the World Health Assembly
Geneva, Switzerland, 23 May 2018 – Today at the 71st World Health Assembly, the World Health Organization (WHO) launched the business case for WHO immunization activities on the African Continent 2018-2030,which outlines how WHO will support African Member States achieve universal immunization coverage.  While Africa has made tremendous progress in improving access to immunization, most countries are off track to achieve the Global Vaccine Action Plan (GVAP) target of 90% national immunization coverage by 2020.Every year, more than 30 million children under-five fall sick due to vaccine-preventable diseases (VP...
Source: WHO EMRO News - May 24, 2018 Category: Middle East Health Source Type: news

Syria: MSF vaccinates tens of thousands of displaced children in west Aleppo
More than 51,000 children were vaccinated  measles, rubella, and pneumococcal disease and its complications.Language English (Source: MSF News)
Source: MSF News - May 8, 2018 Category: International Medicine & Public Health Authors: Elias Primoff Source Type: news

From Declaration to Action: Improving Immunization in Africa
Inviolate Akinyi, a 46-year-old grandmother, got her granddaughter immunized using a mix of private and public clinics. Credit: Veronique Magnin – Habari Kibra VolunteerBy Joyce NgangaNAIROBI, Kenya, Apr 25 2018 (IPS)Inviolate Akinyi, a 46-year-old grandmother, is certain that her grand-daughter needs to get all her vaccines for her to grow up healthy and strong. She uses a mix of private and public clinics in Kibera, one of the largest informal settlement in Nairobi, to get the 15-month-old the shots she needs. Mary Awour, mother to two-year-old Vilance Amondi, also believes immunization is important to protect her ...
Source: IPS Inter Press Service - Health - April 25, 2018 Category: International Medicine & Public Health Authors: Joyce Nganga Tags: Africa Aid Featured Global Headlines Health Human Rights Humanitarian Emergencies Inequity IPS UN: Inside the Glasshouse Population Poverty & SDGs TerraViva United Nations Source Type: news

Pfizer Granted FDA Breakthrough Therapy Designation for Trumenba (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Children Ages 1 to 9 Years
Monday, April 23, 2018 - Pfizer Inc. (NYSE: PFE) today announced that Trumenba (Meningococcal Group B Vaccine) received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for active immunization to prevent invasive... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 23, 2018 Category: Drugs & Pharmacology Source Type: news

What Causes Hyponatremia?
Discussion Normal kidneys regulate water balance to maintain a plasma osmolality of 275-290 mOsm/kg normally. Thirst and arginine vasopressin or antidiuretic hormone (ADH) are the primary regulators of plasma osmolality. ADH is made in the hypothalamus and released by the posterior pituitary gland. ADH acts on the kidney’s distal collecting duct to increase water reabsorption. ADH is appropriately released in hypovolemic states, such as dehydration caused by gastroenteritis. ADH has an ~10 minute half-life and therefore can respond to rapid changes in volume status. Sodium balance is regulated by aldosterone (as part...
Source: PediatricEducation.org - April 23, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

World Immunization Week 2018: Protected Together, #VaccinesWork
22 April 2018, Cairo – This year’s World Immunization Week campaign, celebrated from 24 to 30 April, aims to highlight that protecting entire communities with vaccines protects everyone and so the theme of this year’s campaign is “Protected Together, #VaccinesWork”.  Immunization is one of the most successful and cost-effective health interventions. Studies show that every US$ 1 spent on childhood immunization returns US$ 44 in economic and social benefits.  Immunization protects everyone – from infants to senior citizens – against disabling illnesses, disability a...
Source: WHO EMRO News - April 22, 2018 Category: Middle East Health Source Type: news

Mali:Mali - Vaccinating 10,000 Children Over 60,000KM of Desert Roads
[MSF] Being vaccinated against diseases like diphtheria, measles, whooping cough, meningitis, pneumonia, yellow fever, and other potentially fatal illnesses is a commonplace event for many children. But in northern Mali, where a combination of insecurity, isolation, and limited health infrastructure means that many communities cannot access health facilities, it can prove difficult to protect children against these illnesses. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 10, 2018 Category: African Health Source Type: news

Pneumococcal vaccine cost  effective in older adults
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2018 Category: Drugs & Pharmacology Source Type: news

Pupil overcomes needle fear to take part in meningitis vaccine trial
A student says she took part in a meningitis vaccine trial as she wanted to help people in the future. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 27, 2018 Category: Consumer Health News Source Type: news

Teenagers urged to take part in meningitis B vaccine trial
Researchers hope the study of 24,000 will cut infections in the young and the wider community. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 27, 2018 Category: Consumer Health News Source Type: news

New vaccine targets pneumonia, blood poisoning, meningitis among children in Canada's North
Federal researchers have collaborated to develop a preventative vaccine for a potentially deadly bacteria that causes pneumonia, blood poisoning and meningitis in children and affecting predominantly children in northern and Indigenous communities. (Source: CBC | Health)
Source: CBC | Health - March 7, 2018 Category: Consumer Health News Tags: News/Canada/Manitoba Source Type: news

Teenage boy dies from meningitis only MONTHS after receiving the vaccine
(Natural News) A teenage boy, vaccinated against four strains of bacterial meningitis, became ill with a deadly form of meningitis just months after receiving the vaccine. Within 72 hours after contracting meningitis, 19-year-old Lewis Hilton lost motor control, stopped breathing on his own, and passed away. Hilton was an active rugby player who was promised... (Source: NaturalNews.com)
Source: NaturalNews.com - March 5, 2018 Category: Consumer Health News Source Type: news

PCPs' Struggle With Adult Pneumococcal Vaccine Recommendations PCPs' Struggle With Adult Pneumococcal Vaccine Recommendations
Which vaccine--or both? Are primary care physicians confused regarding the current adult pneumococcal vaccine recommendations?Journal of the American Board of Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 28, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Pneumococcal Vaccine, Polyvalent
(Source: What's New at CBER)
Source: What's New at CBER - February 27, 2018 Category: Biomedical Science Source Type: news

Meningitis B family 'disgusted' over lack of action
Health Minister Steven Brine will face MP's to explain why a vaccines report has yet to be published. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 27, 2018 Category: Consumer Health News Source Type: news

Rural/Urban Disparities in Pneumococcal Vaccine Service Delivery Among the Fee-for-Service Medicare Population
The objective of this study was to identify rural versus urban disparities in pneumococcal vaccine provision in the elderly (age 65 or older) adult population and assess the impact of pharmacy as an alternate site provider in rural communities. (Source: HSR Information Central)
Source: HSR Information Central - February 22, 2018 Category: International Medicine & Public Health Source Type: news

Confused About the Pneumococcal Vaccine Schedule? You're Not Alone Confused About the Pneumococcal Vaccine Schedule? You're Not Alone
Dr Arefa Cassoobhoy highlights a study showing that many clinicians are unclear on pneumococcal vaccination schedules for adults.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 16, 2018 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

MSF Challenges Pfizer's Monopoly on Lifesaving Pneumonia Vaccine in South Korea
Press releaseMSF Challenges Pfizer's Monopoly on Lifesaving Pneumonia Vaccine in South KoreaFebruary 06, 2018The international medical humanitarian organization Doctors Without Borders/M édecins Sans Frontières (MSF) has filed a legal petition to the Supreme Court of South Korea requesting that the court review Pfizer’s patent to for its pneumococcal conjugate vaccine (PCV). On November 29, 2017, the Patent Court of Korea upheld the patent granted to Pfizer for its PCV13 product , marketed as Prevnar13. Unmerited patents like this are a barrier for people, governments, and treatment providers, such...
Source: MSF News - February 6, 2018 Category: International Medicine & Public Health Authors: Brienne Prusak Source Type: news

Meningitis vaccination strategy in Africa found to be effective, economical
Led by YSPH ’s Reza Yaesoubi, an international team of scientists has used a mathematical model to improve vaccination strategies in Africa’s “meningitis belt.” (Source: Yale Science and Health News)
Source: Yale Science and Health News - January 30, 2018 Category: Universities & Medical Training Source Type: news

Primary Care Docs Unsure on Pneumococcal Vaccine Guidelines Primary Care Docs Unsure on Pneumococcal Vaccine Guidelines
A nationwide survey showed that primary care physicians enthusiastically support pneumococcal pneumonia vaccination guidelines but show important knowledge gaps; EHR prompts improve vaccination rates.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 29, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Synthetic DMARDs May Blunt Pneumococcal Vaccine Response in Systemic Sclerosis Synthetic DMARDs May Blunt Pneumococcal Vaccine Response in Systemic Sclerosis
Pneumococcal vaccination yields a satisfactory antibody response in patients with systemic sclerosis (SSc), but synthetic disease-modifying antirheumatic drugs (DMARDs) might reduce the vaccine response in these individuals, according to a report from Sweden.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 24, 2018 Category: Consumer Health News Tags: Rheumatology News Source Type: news

New Data on Bivalent Meningococcal B Vaccine Safety, Efficacy New Data on Bivalent Meningococcal B Vaccine Safety, Efficacy
Pfizer's bivalent meningococcal B vaccine targeting factor H-binding protein (MenB-FHbp, Trumenba) elicits bactericidal responses against diverse meningococcal B strains after the second and third doses in adolescents and young adults, according to two phase 3 studies published online December 14 in The New England Journal of Medicine.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 27, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Your NEJM Group Today: Sexual Harassment in Medicine / Bivalent Meningococcal B Vaccine / NYC Primary Care Opportunity
Here's what we chose for you from NEJM Group today: New England Journal of Medicine: Perspective: A physician and researcher makes the case that sexual... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 14, 2017 Category: Primary Care Source Type: news

Meningitis B warning: Grieving parents of boy, 6, call for all children to be vaccinated
THE GRIEVING parents of a six-year-old boy who died from Meningitis B are calling for all children to be vaccinated against the deadly strain of the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - December 12, 2017 Category: Consumer Health News Source Type: news

Vaccination plea after Halesworth boy's meningitis death
The parents of a boy, six, who died from meningitis B have called on all children to be vaccinated. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 8, 2017 Category: Consumer Health News Source Type: news

Why did baby Kia get horrific meningitis?
Kia Gott, 11-month-old, was rushed to hospital with meningitis C in September. Her parents Paul Gott and Vikki Mitchell are petitioning for the meningitis C vaccine to be reinstated. (Source: the Mail online | Health)
Source: the Mail online | Health - December 6, 2017 Category: Consumer Health News Source Type: news

The Ratcheting Price of the Pneumococcal Vaccine: What Gives? The Ratcheting Price of the Pneumococcal Vaccine: What Gives?
The price for Pfizer ’ s Prevnar 13 has increased 5 to 6 percent each year since its 2010 approval by the Food and Drug Administration.Kaiser Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2017 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Latest meningitis vaccine prevents almost all forms
A recently-developed meningitis vaccine can prevent nine out of the 10 strains of the virus found tin the US, according to new research from the CDC. The vaccine was approved in 2015. (Source: the Mail online | Health)
Source: the Mail online | Health - November 22, 2017 Category: Consumer Health News Source Type: news